Breaking News

Cognizant to Buy Trizetto for About $2.7 Billion in Merger of Healthcare IT Providers
Tweet TWEET

Signum Dermalogix Partners with Elizabeth Arden, Launches Product Containing Cosmetic Functional Ingredient Arazine™

 Signum Dermalogix Partners with Elizabeth Arden, Launches Product Containing
                   Cosmetic Functional Ingredient Arazine™

PR Newswire

PRINCETON, N.J., Feb. 26, 2013

PRINCETON, N.J., Feb. 26, 2013 /PRNewswire/ -- Signum Dermalogix Inc.,  a
private biopharmaceutical company focused on developing new and innovative
dermatological products and services has entered into a partnership with
Elizabeth Arden, Inc. focusing on a semi-exclusive global license for the
cosmetic functional ingredient Arazine™ (N-acetyl-S-farnesyl-cysteine) as well
as developing new screening methodologies to measure the anti-oxidant
potential of Arden's other product ingredients.

Arazine™, initially discovered at Princeton University possesses
anti-inflammatory and anti-oxidant properties making it an ideal complement
with Idebenone-ester as key ingredients in Elizabeth Arden's Prevage®
Anti-aging + Intensive Repair Daily Serum product.

Arazine™ is the first cosmetic ingredient from Signum Dermalogix's novel
technology platform to be commercialized. Maxwell Stock, CEO of Signum
Dermalogix commented, "We are excited about our partnership with Arden
especially given their commitment to bringing a scientific approach to
developing new and innovative skin care products. We believe this is just the
beginning of a dynamic collaboration that will enable the development of a
first in class line of skin care products."

Dr. Eduardo Perez, VP of R&D stated, "With Elizabeth Arden's decades of
experience in skin care and our R&D and chemical expertise, we look forward to
assisting Elizabeth Arden's efforts in producing innovative, high quality skin
care products supported with robust scientific data."

Given the successful launch of Arazine™ in the Prevage® line, Signum
Dermalogix is now focused on developing a second generation of novel cosmetic
ingredients as well as finding a partner to commercialize Arazine™ in the
physician dispensed channel.

About Signum Dermalogix
Signum Dermalogix was founded in 2011 and is a spin‐out of Signum Biosciences.
Signum Dermalogix is a dermatology focused company developing novel cosmetic
ingredients and drug compounds. Signum Dermalogix also provides dermatology
testing, custom assay development and analytical services. For more
information please visit: www.signumdermalogix.com.

About Elizabeth Arden
Elizabeth Arden is a global prestige beauty products company with an extensive
portfolio of prestige beauty brands sold in over 100 countries. The company's
brand portfolio includes Elizabeth Arden skincare, color, and fragrance
products, PREVAGE® anti-aging formulas, the celebrity fragrance brands of
Britney Spears, Elizabeth Taylor, Mariah Carey, Taylor Swift, and Usher; the
designer fragrance brands of Juicy Couture, Alberta Ferretti, Alfred Sung,
Badgley Mischka, Bob Mackie, Geoffrey Beene, Halston, John Varvatos, Kate
Spade, Lucky Brand, and Rocawear; and the lifestyle fragrance brands Curve,
Giorgio Beverly Hills, and PS Fine Cologne.



SOURCE Signum Dermalogix Inc.

Website: http://www.signumdermalogix.com
Contact: Eduardo Perez, +1-732-329-6344, eperez@signumbio.com
 
Press spacebar to pause and continue. Press esc to stop.